|Selected news articles which highlight important policy issues.||
News: Weekly Archives
News for the week of 06-30-2006
Panel Unanimously Recommends Cervical Cancer Vaccine for Girls 11 and Up
The latest news of the federal recommendation of widespread distribution of Merck's new vaccine for cervical cancer, Gardasil, is promising for women around the world. As part of the recommended list of vaccines, Merck's new drug Gardasil will be placed in the federal Vaccine Injury Compensation program, a spot that will limit Merck's liability exposure and encourage further drug distribution and research.
A federal vaccine advisory panel voted unanimously yesterday to recommend that all girls and women ages 11 to 26 receive a new vaccine that prevents most cases of cervical cancer.
|home spotlight commentary research events news about contact links archives|